Peter Maag

Peter K.
Maag currently serves as Independent Director at CareDx, Inc. since 2021.
He is Director at Personalized Medicine Coalition and Blulake Ventures LLC.
He is a Member of the Supervisory Board at PHOENIX Pharmahandel GmbH & Co. KG and PHOENIX Pharma SE since 2012.
Formerly, Dr. Maag was Chief Executive Officer & Director at Kyverna Therapeutics, Inc. from 2022 to 2024.
He was Independent Director at Miromatrix Medical, Inc. from 2021 to 2023.
He served as Director at MolecularMD Corp.
from 2012 to 2020.
He was Director at Zuellig Pharma Corp.
from 2003 to 2005.
He held multiple roles at Novartis International AG from 2001 to 2012, including Global Head-Novartis Diagnostics.
He was Global Head-Novartis Diagnostics at Novartis AG from 2009 to 2012 and Head-Strategy at Novartis AG from 2001 to 2002.
He was President at Novartis Vaccines & Diagnostics, Inc. from 2009 to 2012, President at Novartis Pharmaceuticals from 2006 to 2008, and Country President at Novartis Pharma AG from 2006 to 2008.
He was President at Novartis Korea Ltd. from 2003 to 2005 and President at Novartis Vaccines & Diagnostics SL.
He was Associate Principal at McKinsey GmbH & Co. KG from 1994 to 2001.
Dr. Maag earned a doctorate from Humboldt-Universität zu Berlin.